Document is current
Any future updates will be listed below
-
Authors
Lewis, Charles P. http://orcid.org/0000-0001-8791-657X
Port, John D. http://orcid.org/0000-0002-4237-7776
Blacker, Caren J. http://orcid.org/0000-0003-3510-0696
Sonmez, A. Irem
Seewoo, Bhedita J.
Leffler, Jarrod M.
Frye, Mark A.
Croarkin, Paul E. http://orcid.org/0000-0001-6843-6503
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (K23 MH100266, R01 MH113700)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health
Brain and Behavior Research Foundation (27488)
- License Information
-
More Information
Article History
Received: 15 September 2019
Revised: 21 February 2020
Accepted: 25 March 2020
First Online: 23 April 2020
Conflict of interest
: C.P.L. receives grant support from the Brain & Behavior Research Foundation as the Alan G. Ross Memorial Investigator. He has been a site investigator for multicenter trials funded by Neuronetics, Inc. and NeoSync, Inc. J.D.P. serves as an imaging consultant for Takeda Pharmaceutical Company, Ltd., Biomedical Systems Corp., and Neuronetics, Inc. C.J.B. receives research support from the Mayo Foundation for Medical Education and Research Departmental Small Grant Program. M.A.F. has received grant support from Assurex Health, Inc., the Mayo Foundation for Medical Education and Research, and Medibio, Ltd.; has served as a paid consultant for Actify Neurotherapies, Allergan plc, Intra-Cellular Therapies, Inc., Janssen Pharmaceuticals, Inc., Myriad Genetics, Inc., Neuralstem, Inc., Takeda Pharmaceutical Company, Ltd., and Teva Pharmaceutical Industries, Ltd.; and has received honoraria or travel support from American Physician Institute, CME Outfitters, LLC, and Global Academy for Medical Education, LLC. P.E.C. has received research grant support from the National Institute of Mental Health and Pfizer, Inc.; equipment support from Neuronetics, Inc.; and has received supplies and genotyping services from Assurex Health, Inc. for investigator-initiated studies. He is the primary investigator for a multicenter study funded by Neuronetics, Inc. and a site primary investigator for a study funded by NeoSync, Inc., and he has served as a consultant for Procter & Gamble Company and Myriad Neuroscience. A.I.S., B.J.S., and J.M.L. have no financial relationships to disclose.
